🔴 Neurosense Therapeutics is trading 10.38% down today; catalyst remains unclear

Neurosense Therapeutics is trading 10.38% down at $3.28, with no confirmed company-specific catalyst identified for October 12.

• The company’s news list shows no announcement on October 12; its latest listed update is dated October 2.
• The October 2 update concerned Nasdaq bid-price compliance and a request for more time on the market-value requirement.
• The Nasdaq was down 0.44%, but the snapshot does not establish a broad-market explanation. No trading volume was provided, and the cause remains unclear.